Reopro removal during cardiopulmonary bypass using a hemoconcentrator.
Poullis
M
M
Department of Cardiothoracic Surgery, Hammersmith Hospital, London, United Kingdom.
Manning
R
R
Haskard
D
D
Taylor
K
K
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000302:isolation & purification*; D016063:Blood Loss, Surgical / Q000517:prevention & control; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D002315:Cardiopulmonary Bypass; D006440:Hemofiltration / Q000379:methods*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000302:isolation & purification*; D010974:Platelet Aggregation; D010975:Platelet Aggregation Inhibitors / Q000302:isolation & purification*; D019106:Postoperative Hemorrhage / Q000097:blood / Q000139:chemically induced / Q000517:prevention & control
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab